These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23389968)

  • 41. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
    Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HBx inhibits the growth of CCL13-HBX-stable cells via the GSK-3beta/beta-catenin cascade.
    Kuo CY; Wu CC; Hsu SL; Hwang GY
    Intervirology; 2008; 51(2):130-6. PubMed ID: 18552505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}.
    Greenspan EJ; Madigan JP; Boardman LA; Rosenberg DW
    Cancer Prev Res (Phila); 2011 Jan; 4(1):161-71. PubMed ID: 21205744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3beta-mediated phosphorylation of beta-catenin.
    Haraguchi K; Ohsugi M; Abe Y; Semba K; Akiyama T; Yamamoto T
    Oncogene; 2008 Jan; 27(3):274-84. PubMed ID: 17621269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polycyclic aromatic hydrocarbons and dibutyl phthalate disrupt dorsal-ventral axis determination via the Wnt/β-catenin signaling pathway in zebrafish embryos.
    Fairbairn EA; Bonthius J; Cherr GN
    Aquat Toxicol; 2012 Nov; 124-125():188-96. PubMed ID: 22975441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia.
    Pandey GN; Rizavi HS; Tripathi M; Ren X
    Bipolar Disord; 2015 Mar; 17(2):160-71. PubMed ID: 25041379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
    Zhang X; Zhong S; Xu Y; Yu D; Ma T; Chen L; Zhao Y; Chen X; Yang S; Wu Y; Tang J; Zhao J
    PLoS One; 2016; 11(4):e0153194. PubMed ID: 27045586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inactivation of glycogen synthase kinase-3β up-regulates β-catenin and promotes chondrogenesis.
    Zhou J; Chen Y; Cao C; Chen X; Gao W; Zhang L
    Cell Tissue Bank; 2015 Mar; 16(1):135-42. PubMed ID: 24760579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
    Oloumi A; Syam S; Dedhar S
    Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts.
    Caraci F; Gili E; Calafiore M; Failla M; La Rosa C; Crimi N; Sortino MA; Nicoletti F; Copani A; Vancheri C
    Pharmacol Res; 2008 Apr; 57(4):274-82. PubMed ID: 18346908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased expression of beta-catenin, phosphorylated glycogen synthase kinase 3beta, cyclin D1, and c-myc in laterally spreading colorectal tumors.
    Wang J; Wang X; Gong W; Mi B; Liu S; Jiang B
    J Histochem Cytochem; 2009 Apr; 57(4):363-71. PubMed ID: 19064714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3β inhibitors to activate Wnt/β-catenin pathway.
    Yue H; Lu F; Shen C; Quan JM
    Bioorg Chem; 2015 Aug; 61():21-7. PubMed ID: 26057861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
    Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ; Janssen A; Schmidt R; Geisslinger G; Grösch S
    FASEB J; 2005 Aug; 19(10):1353-5. PubMed ID: 15946992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influenza A virus infection of vascular endothelial cells induces GSK-3β-mediated β-catenin degradation in adherens junctions, with a resultant increase in membrane permeability.
    Hiyoshi M; Indalao IL; Yano M; Yamane K; Takahashi E; Kido H
    Arch Virol; 2015 Jan; 160(1):225-34. PubMed ID: 25385175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concomitant degradation of beta-catenin and GSK-3 beta potently contributes to glutamate-induced neurotoxicity in rat hippocampal slice cultures.
    Lee JH; Lee EO; Kang JL; Chong YH
    J Neurochem; 2008 Aug; 106(3):1066-77. PubMed ID: 18445133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of Akt/GSK-3beta/beta-catenin signaling pathway is involved in survival of neurons after traumatic brain injury in rats.
    Zhao S; Fu J; Liu X; Wang T; Zhang J; Zhao Y
    Neurol Res; 2012 May; 34(4):400-7. PubMed ID: 22643085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crossregulation of NF-kappaB by the APC/GSK-3beta/beta-catenin pathway.
    Deng J; Xia W; Miller SA; Wen Y; Wang HY; Hung MC
    Mol Carcinog; 2004 Mar; 39(3):139-46. PubMed ID: 14991743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].
    Cao Q; Feng YJ
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):804-9. PubMed ID: 17415999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Galangin suppresses the proliferation of β-catenin response transcription-positive cancer cells by promoting adenomatous polyposis coli/Axin/glycogen synthase kinase-3β-independent β-catenin degradation.
    Gwak J; Oh J; Cho M; Bae SK; Song IS; Liu KH; Jeong Y; Kim DE; Chung YH; Oh S
    Mol Pharmacol; 2011 Jun; 79(6):1014-22. PubMed ID: 21406604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.